Azitra, Inc. Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent
Azitra, Inc. (AZTR) reported Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent of -1.19% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent · last filed 2025-02-24
- Azitra, Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2024 was -1.19%.
- Azitra, Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2023 was -0.49%.
- Azitra, Inc. effective income tax rate reconciliation,other reconciling items, percent for fiscal 2022 was -0.85%.
| Period end | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -1.19% 10-K · filed 2025-02-24 | |
| 2023-12-31 | -0.49% 10-K · filed 2025-02-24 | -0.42% 10-K · filed 2024-03-15 |
| 2022-12-31 | -0.85% 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |